SCHEMBL7309199

SCHEMBL7309199

COc1ccccc1/C=C/c1ccc([S+]([O-])C(CC(=O)NO)Cc2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 2/20 0.44
TRPA1 O75762 1/20 0.44
CAPN1 P07384 2/20 0.42
PDE4A P27815 3/20 0.41
PDE4B Q07343 3/20 0.41
PDE4C Q08493 3/20 0.41
PDE4D Q08499 3/20 0.41
SNCA P37840 2/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
CYP1A1 P04798 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP1B1 Q16678 2/20 0.40
KDM4E B2RXH2 1/20 0.39
CYP19A1 P11511 1/20 0.39
BIRC2 Q13490 1/20 0.38
MME P08473 1/20 0.38
LTA4H P09960 1/20 0.38
ANPEP P15144 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7309205 0.82 MMP2 (0.51) PDE4APDE4BPDE4CPDE4DSNCA
SCHEMBL7303121 0.82 MMP2 (0.60) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7312050 0.79 PDE4A (0.69) NFE2L2TRPA1PDE4APDE4BPDE4C
SCHEMBL7309376 0.78 CYP1A1 (0.49) NFE2L2TRPA1CAPN1PDE4APDE4B
SCHEMBL7303135 0.77 MME (0.47) MMP1MMP2MMELTA4HANPEP
SCHEMBL7308706 0.77 MMP1 (0.46) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7303711 0.75 MMP2 (0.51) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL7299652 0.74 MME (0.44) MMP1MMELTA4HANPEPECE1
SCHEMBL7308918 0.72 FCER2 (0.48) PDE4APDE4BPDE4CPDE4DMMP1
SCHEMBL27477944 0.72 MME (0.42) MMP1MMELTA4HANPEPECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed